Medicinal – Page 69

Flammulina velutipes polysaccharides exhibit potent antioxidant and anti-pyroptotic properties in diabetes-associated periodontitis: A preliminary in vitro study

mycolabadmin

Researchers studied a compound from the Flammulina velutipes mushroom (enoki mushroom) to see if it could help protect gum tissue in people with both diabetes and gum disease. Using human gum cell samples exposed to disease-simulating conditions, they found that the mushroom polysaccharides reduced cell damage, decreased inflammation, and prevented a harmful type of cell death called pyroptosis. The results suggest this mushroom compound could potentially be used as a supplementary treatment for people with diabetes-related gum disease.

Phytochemical Composition and Wound Healing Properties of Echinacea angustifolia DC. Root Hydroalcoholic Extract

mycolabadmin

Echinacea angustifolia, a traditional medicinal plant, was studied for its wound-healing abilities using laboratory tests. Scientists found that the plant extract contains powerful antioxidant compounds, particularly one called echinacoside, and can help skin cells move and multiply to close wounds faster. The extract also reduces inflammation and protects cells from damage, supporting its long-standing traditional use for treating wounds and burns.

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

Nail fungal infections caused by Candida albicans can be difficult to treat when the fungus becomes resistant to common antifungal medications like itraconazole. Researchers found that resistant strains have overactive genes that pump the drug out of fungal cells and genes that help the fungus form protective biofilm structures. Understanding these resistance mechanisms could lead to better combination treatments that block these protective strategies.

Sporothrix is neglected among the neglected

mycolabadmin

Sporotrichosis is a fungal infection caused by Sporothrix species that usually affects the skin but can spread to joints, lungs, and eyes. While traditionally spread through plant material during gardening, the disease has increasingly spread between cats and humans through bites and scratches, particularly in South America and other regions. The fungus is developing resistance to common antifungal drugs, and scientists worry climate change could expand where this disease occurs worldwide.

Improving the production of micafungin precursor FR901379 in Coleophoma empetri using heavy-ion irradiation and its mechanism analysis

mycolabadmin

Researchers used heavy-ion radiation to create improved strains of a fungus that produces a precursor to micafungin, an important antifungal drug. The improved strains produced over 3.5 times more of the desired compound than the original strain. By analyzing the genetic changes in these improved strains, the scientists identified which genes were most important for boosting production, helping guide future improvements in manufacturing this life-saving medicine.

Two Cases of Fungal Melanonychia

mycolabadmin

Two patients developed dark pigmentation on their toenails caused by rare combinations of fungal infections. Through laboratory testing and genetic analysis, doctors identified fungi never before known to cause this type of nail discoloration. Both patients were successfully treated with an antifungal medication called efinaconazole, with complete resolution of symptoms within a few months.

mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million

mycolabadmin

Scientists have discovered about 30,000 fungal compounds with useful properties, from life-saving antibiotics like penicillin to cholesterol-lowering drugs. However, new research suggests that fungi actually produce somewhere between 1.4 million and 4.3 million different chemical compounds, meaning we’ve only discovered about 1-2% of what’s out there. By studying the genomes of fungi, researchers estimate that for every fungal medicine we know about, there could be 50-100 more waiting to be discovered, representing an enormous opportunity for developing new drugs and therapies.

A rare case of invasive necrotizing myositis of the thigh caused by Basidiobolus ranarum: a multi-pronged approach to successfully managing a near-fatal polybacterial mycotic infection

mycolabadmin

A 46-year-old man developed a severe, spreading infection of his thigh muscle caused by a rare fungus called Basidiobolus ranarum, likely from an insect bite years earlier that was neglected. The infection became life-threatening when bacteria also invaded the tissue, causing widespread muscle death and bloodstream infection. Doctors treated him with multiple antifungal medications, antibiotics, surgery, and eventually had to amputate his leg to save his life. After six weeks of intensive care combining several medications including potassium iodide and extended oral antifungal therapy, the wound finally healed.

Prevalence of fungi and their antifungal and disinfectant resistance in hospital environments: insights into combating nosocomial mycoses

mycolabadmin

This study examined fungal contamination in hospital intensive care units, finding that Aspergillus and other mold species are commonly present in air and ventilation systems. Importantly, many of these fungi have developed resistance to antifungal medications and hospital disinfectants, making them harder to treat and control. The researchers discovered that the same resistant fungi found in hospitals are similar to those infecting patients, suggesting that hospital environments may be spreading these dangerous infections.

Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus

mycolabadmin

Researchers developed a simple and affordable test called the LODDY Test to identify a dangerous yeast called Lodderomyces elongisporus that is often mistaken for a similar but less dangerous yeast. This test uses color changes on a special culture medium to distinguish between different yeast species in just 48 hours without expensive equipment. The test works perfectly in laboratories worldwide and could help doctors in developing countries diagnose and treat serious fungal infections more quickly and accurately.

Research Topic: Medicinal